Bill Wilson, MD: GLP-1 Drugs May Curb Addiction, Obesity, and More—A Game-Changer in Medicine
A short interview excerpt where Dr. Ron Najafi asks Dr. Bill Wilson about the potential for GLP-1 receptor agonist drugs to treat addictive behaviors. Dr. Wilson suggests a link between 'carb syndrome' and broadened cravings (nicotine, alcohol, drugs) and says GLP-1 drugs appear to blunt those cravings, though the precise brain biology remains unclear.
Chapters
More from Dr.
Hippocrates said, let thy food be thy medicine #obesity #metabolicsyndrome #lustig #shorts #health
Bill Wilson, MD: Why GLP-1 Drugs Are Overpriced—and How Compounding and Competition Could Fix It
Nitrosamine in Pharmaceutical Products? A Deep Dive into Risk Management by Ron Najafi, Ph.D.
The Subcellular Processes That Belie All Chronic Disease. The Hateful (or Grateful) Eight #lustig
Bill Wilson, MD: GLPs May Reverse Carb Syndrome—Helping Patients Reach Zero and Sustain with Diet
Why Everything You Knew About Obesity Is Wrong | Dr. Robert Lustig on Sugar & Metabolic Syndrome
Robert Lustig, MD: How Fructose Fuels Fatty Liver, Oxidative Stress, and Metabolic Disease #fructose
Robert Lustig, MD: The 3 Types of Fat Fueling Insulin Resistance and Disease #insulin resistance
Bill Wilson, MD: GLPs May Reverse CARB Syndrome. Helping Patients Reach Zero and Sustain with Diet